Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Penetran+Plus** is a branded over-the-counter topical analgesic lotion or gel developed as a non-menthol, non-salicylate product for temporary relief of minor muscle and joint aches, bruises, strains, sprains, simple backache, and pain associated with arthritis. Product labeling identifies strong ammonia solution as the analgesic active ingredient; marketed versions have also contained methylsulfonylmethane and lemon oil among inactive formulation ingredients. Transdermal Delivery Solutions licensed the product to MHC Medical Products in 2016 to expand its OTC distribution. ([biospace.com](https://www.biospace.com/b-transdermal-delivery-solutions-b-and-b-mhc-medical-products-b-announce-license-for-penetran-plus-topical-pain-reliever))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Penetran+Plus.